EIF2AK3 and depressive disorder: Strengths of this study include the diverse, multicenter cohort, the rigor of the depression ascertainment, the concomitant characterization of PERK haplotypes, biomarkers of inflammation and immune activation, the biomarker dimensionality reduction approach, and the breadth of characterization of impact on activities of daily living and quality of life.